Therapeutic compositions for treatment of a damaged tissue

Details Therapeutic compositions for treatment of a damaged tissue Therapeutic compositions for treatment of a damaged tissue

2005-12-13

2005-12-13

Weber, Jon (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S054000, C530S356000, C530S395000, C562S433000, C436S071000, C436S089000, C424S009100

Reexamination Certificate

active

06974796

ABSTRACT:
The present invention relates to a therapeutic composition and uses thereof for treatment of damaged tissue, wherein the composition comprises at least one extracellular matrix compound, at least one polar surface active lipid, and a plurality of amino acids having a molar ratio which is characteristic of human breast milk protein; and further comprises a fatty acid, gamma-amino butyric acid or L-carnitine.

REFERENCES:
patent: 5236899 (1993-08-01), Durette
patent: 5753211 (1998-05-01), Garson et al.
patent: 6479059 (2002-11-01), Montanari et al.
patent: WO 92/21752 (1992-12-01), None
Henschen et al., Ann N. Y. Acad. Sc. 408, 28-43 (1983).
Wayman et al., Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after transplantation.The Journal of Pediatrics, 31(6), 894-898 (Dec. 1977.
Neocate Product Information Sheet, downloaded from www.shsweb.co.uk on Jul. 20, 2000.

Affiliated with

Also associated with

Rating

Therapeutic compositions for treatment of a damaged tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compositions for treatment of a damaged tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions for treatment of a damaged tissue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3516122